A side-by-side comparison using 8,960 real patient posts from Reddit and published clinical trial data. Not medical advice — evidence to inform your conversation with your doctor.
Clinical trial results at the highest studied doses. No head-to-head trial exists — these are cross-trial comparisons.
These trials enrolled different populations. TRIUMPH-4 participants had obesity plus knee osteoarthritis (mean BMI 40.4). SURMOUNT-1 enrolled general obesity (mean BMI 38.0). A direct head-to-head trial would be needed for definitive conclusions. The magnitude of difference is consistent with retatrutide’s triple-agonist mechanism providing additional metabolic activity via the glucagon receptor.
Percentage of Reddit posts for each drug mentioning each side effect, with raw post counts shown. Based on 3,580 retatrutide and 5,380 tirzepatide posts.
| Side Effect | Retatrutide | Tirzepatide | Signal |
|---|---|---|---|
| Nausea | 14.2%509 posts | 14.3%769 posts | Similar rates. Both lower than semaglutide (21.2%). |
| Fatigue | 12.6%450 posts | 9.1%488 posts | Reta slightly elevated by percentage. |
| Heart Rate Increase | 7.2%257 posts4.2× | 2.4%128 posts | Reta-Specific Appears at first injection, not dose-dependent. Likely binary — you either get it or you don’t. |
| Insomnia | 6.4%230 posts3.4× | 3.0%163 posts | Reta-Specific 4.5× more common in first 4 weeks. Usually self-resolving. |
| Skin Sensitivity | 5.6%199 posts7.4× | 1.0%52 posts | Reta-Specific Dose-dependent: 3% at 1mg → 25% at 12mg. Confirmed by Phase 3 at 20.9%. |
| Diarrhea | 5.9%210 posts | 5.2%279 posts | Similar rates. |
| Hair Loss | 1.3%47 posts | 4.2%228 posts3.4× | Tirz-Elevated Telogen effluvium from rapid weight loss. Appears months 3–6. |
| Constipation | 3.7%132 posts | 5.8%311 posts | Tirz nearly 2× reta. |
| Low Libido | 1.5%54 posts5× | 0.4%23 posts | Reta-Specific Not measured in any clinical trial. Reddit-only data point. |
| Gallbladder Issues | 0.3%10 posts | 1.3%71 posts | Tirz elevated. Often severe when it occurs. |
Retatrutide has a more aggressive side effect profile with unique cardiovascular (heart rate, 257 posts), neurological (insomnia, 230 posts), and dermatological (skin sensitivity, 199 posts) signals largely absent from tirzepatide. Tirzepatide’s main burdens are hair loss (228 posts, 3.4× reta) and constipation (311 posts). Both drugs have similar GI profiles for nausea and diarrhea.
Published trial results compared to what 8,960 Reddit users reported. Arrows show whether Reddit under- or over-counts relative to trials.
| Side Effect | Reta Trial | Reta Reddit | Tirz Trial | Tirz Reddit | Pattern |
|---|---|---|---|---|---|
| Nausea | 43% | 14.2%509 | 31% | 14.3%769 | ↓ Undercounted |
| Vomiting | 21% | 0.9%31 | 12.2% | 1.8%97 | ↓↓ Heavily under |
| Diarrhea | 15% | 5.9%210 | 23% | 5.2%279 | ↓ Undercounted |
| Skin Sensitivity | 20.9% | 5.6%199 | N/A | 1.0%52 | ↓ Undercounted |
| Fatigue | 7–10% | 12.6%450 | N/A | 9.1%488 | ↑ Overcounted |
| Insomnia | Not captured | 6.4%230 | Not captured | 3.0%163 | ★ New signal |
| Low Libido | Not measured | 1.5%54 | Not measured | 0.4%23 | ★ New signal |
| Hair Loss | N/A | 1.3%47 | OR 5.76 | 4.2%228 | → Consistent |
Reddit systematically undercounts acute GI symptoms (nausea, vomiting, diarrhea) because people don’t open Reddit mid-episode. It overcounts quality-of-life effects like fatigue because those are what drive people to post. Clinical trials miss insomnia, low libido, and craving reduction because they don’t ask about them. The two data sources are genuinely complementary — neither tells the whole story alone.
Side effects and patterns invisible to clinical research by design.
When Reddit data and clinical trials measure the same thing, the numbers are close. Our data found retatrutide skin sensitivity at 5.6% (199 posts), which aligned with the Phase 2 trial finding of 7%. Phase 3 TRIUMPH-4 results (December 2025) later reported 20.9% at 12mg, consistent with the dose-dependent pattern visible in our data (3% at 1mg → 25% at 12mg). This overlap gives us confidence in the signals Reddit captures that trials don’t measure.
Of all side effect reports, what percentage were rated mild, moderate, or severe.
Despite having more unique side effects, retatrutide has a lower severe side effect rate (22% of 3,097 reports) than tirzepatide (27% of 3,701 reports). This likely reflects retatrutide’s self-selecting user base — more experienced users who titrate slowly and manage side effects proactively.
Positive effects reported beyond weight loss, with raw post counts. Benefits are underreported — people post about problems more than wins.
| Benefit | Retatrutide | Tirzepatide | Signal |
|---|---|---|---|
| Food Noise Eliminated | 23.8%853 posts | 18.0%967 posts | Tirz has more raw mentions (734 vs 560). Reta has higher rate per user. Both strongly reported. |
| Energy Increased | 10.0%357 posts | 12.3%663 posts | Tirz leads in both rate and raw count. |
| Blood Pressure Normalized | 2.5%90 posts | 7.3%393 posts | Both strong. TRIUMPH-4 showed −14mmHg systolic on reta 12mg. |
| Inflammation Reduced | 4.2%152 posts | 7.1%384 posts | Tirz leads. Joint pain and CRP improvements frequently cited. |
| Mental Clarity | 3.9%139 posts | 6.2%331 posts | Similar rates. |
| Reduced Alcohol Cravings | 3.9%139 posts | 3.2%173 posts | Uniform across all drugs — mechanism-level GLP-1 effect. |
Tirzepatide has the stronger overall benefit profile with more raw reports across energy (663 vs 357), inflammation (384 vs 152), and blood pressure (393 vs 90). Both drugs show strong food noise elimination. Alcohol craving reduction is uniform across all GLP-1 drugs, suggesting a mechanism-level effect rather than drug-specific.
What happens when people switch — and why the flow is one-directional.
The switching is heavily one-directional because the motivations are opposite. Tirz→reta switchers are chasing results. Reta→tirz switchers are seeking stability, insurance, or an approved medication. Both are rational decisions for different stages of the weight loss journey. For a detailed look at what the transition actually looks like — appetite changes, dosing, timeline — see our switching to retatrutide analysis.
Based on the data — not a recommendation. Always discuss with your healthcare provider.
Search all 14,252 posts across retatrutide, tirzepatide, and semaglutide.
22-page analysis — side effects, remedies, benefits, women’s health, clinical trial comparisons, and recommendations by drug.